Members only publications are marked with a lock icon:

Filter By
October 4, 2016

Nurse Assist, Inc. announced today that it is voluntarily recalling all unexpired lots of I.V. Flush Syringes due to a potential link to Burkholderia cepacia (B. cepacia) bloodstream infections with the product. Please click here for more information.

August 23, 2016

On August 23, 2016, the Centers for Disease Control and Prevention (CDC) released a report on sepsis that will focus on preventing infections that lead to sepsis and the importance of sepsis early recognition. The report will be release as part of CDC’s Vital Signs series, which focuses on critical public health issues. This monthly report CDC...

August 10, 2016

FDA released an updated statement including a voluntary recallExternal Web Site Icon of all of liquid products manufactured by PharmaTech and distributed by: Rugby, Major, Bayshore, Metron, Centurion, and Virtus. Read more.

July 20, 2016


Pneumococcal disease is known to have a potentially serious impact in frail individuals, particularly those residing in post-acute and long-term care settings where outbreaks have been demonstrated and which could have been prevented by adequate vaccination.

Two pneumococcal vaccines are currently licensed and...

July 18, 2016

Case count corrected as of July 18, 2016. CDC has confirmed 49 cases from 5 states. Read more.

July 16, 2016

FDA has released a statement regarding a voluntary recallExternal Web Site Icon of certain liquid docusate products. The extent of this issue remains under investigation; therefore, both FDA and CDC continue to recommend that clinicians and patients not use any liquid docusate sodium product as a stool softener or for any other medical purpose...

July 8, 2016

The CDC is collaborating with the Food and Drug Administration (FDA), multiple state and local health departments, and healthcare facilities to investigate a multi-state outbreak of Burkholderia cepacia infections. These infections have occurred primarily in ventilated patients without cystic fibrosis and who are being treated in intensive care...

May 12, 2016

The U.S. Food and Drug Administration is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, fluoroquinolones should be...

May 10, 2016

FDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. FDA is adding a new warning to the drug labels for all olanzapine-containing products that describes this severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS...

April 19, 2016


  1. Why get vaccinated for pneumococcal disease?
    The most effective way to treat pneumococcal disease is to prevent it through immunization.

    Pneumococcal disease is a common, yet potentially serious infection caused by Streptococcus

  2. ...